Expression of matrix metalloproteinase-26 and tissue inhibitors of metalloproteinases TIMP-3 and -4 in benign endometrium and endometrial cancer*

By Tunuguntla R.   Ripley D.   Sang Q.-X.A.   Chegini N.  

Gynecologic Oncology, Vol. 89, Iss. 3, 2003-06 ,pp. : 453-459

Elsevier

Access to resources Recommend Favorite

Association of cyclooxygenase-2 and matrix metalloproteinase-2 expression in human breast cancer

By Sivula Anna  

Breast Cancer Research and Treatment, Vol. 89, Iss. 3, 2005-02 ,pp. : 215-220

Springer Publishing Company

Access to resources Recommend Favorite

Activated Matrix Metalloproteinase-2-A Potential Marker of Prognosis for Epithelial Ovarian Cancer

By Wu X.   Li H.   Kang L.   Li L.   Wang W.   Shan B.  

Gynecologic Oncology, Vol. 84, Iss. 1, 2002-01 ,pp. : 126-134

Elsevier

Access to resources Recommend Favorite

A pilot study of the safety and effects of the matrix metalloproteinase inhibitor marimastat in gastric cancer

By Tierney G.M.   Griffin N.R.   Stuart R.C.   Kasem H.   Lynch K.P.   Lury J.T.   Brown P.D.   Millar A.W.   Steele R.J.C.   Parsons S.L.  

European Journal of Cancer, Vol. 35, Iss. 4, 1999-04 ,pp. : 563-568

Elsevier

Access to resources Recommend Favorite

The plasminogen activator and matrix metalloproteinase systems in colorectal cancer - relationship to tumour pathology

By Baker E.A.   Leaper D.J.  

European Journal of Cancer, Vol. 39, Iss. 7, 2003-05 ,pp. : 981-988

Elsevier

Access to resources Recommend Favorite